Molecule Holdings Inc.
MLCL
CNSX
| 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.33M | 1.38M | 1.61M | 1.53M | 1.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.33M | 1.38M | 1.61M | 1.53M | 1.25M |
| Cost of Revenue | 1.67M | 1.98M | 2.39M | 2.35M | 1.77M |
| Gross Profit | -337.00K | -593.80K | -779.00K | -825.10K | -525.00K |
| SG&A Expenses | 1.56M | 1.68M | 1.93M | 2.18M | 2.14M |
| Depreciation & Amortization | 54.70K | 30.00K | 30.50K | 31.00K | 28.90K |
| Other Operating Expenses | -- | -- | -- | -- | 0.00 |
| Total Operating Expenses | 3.28M | 3.69M | 4.35M | 4.56M | 3.95M |
| Operating Income | -1.95M | -2.30M | -2.74M | -3.03M | -2.70M |
| Income Before Tax | -2.66M | -2.65M | -2.90M | -3.47M | -3.00M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.66 | -2.65 | -2.90 | -3.47 | -3.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.66M | -2.65M | -2.90M | -3.47M | -3.00M |
| EBIT | -1.95M | -2.30M | -2.74M | -3.03M | -2.70M |
| EBITDA | -1.50M | -1.84M | -2.25M | -2.54M | -2.22M |
| EPS Basic | -0.03 | -0.03 | -0.03 | -0.04 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.03 | -0.04 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 391.14M | 390.92M | 390.48M | 388.47M | 385.96M |
| Average Diluted Shares Outstanding | 391.14M | 390.92M | 390.48M | 388.47M | 385.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |